194 related articles for article (PubMed ID: 33093518)
1. High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturing.
Lissandrello CA; Santos JA; Hsi P; Welch M; Mott VL; Kim ES; Chesin J; Haroutunian NJ; Stoddard AG; Czarnecki A; Coppeta JR; Freeman DK; Flusberg DA; Balestrini JL; Tandon V
Sci Rep; 2020 Oct; 10(1):18045. PubMed ID: 33093518
[TBL] [Abstract][Full Text] [Related]
2. Scalable continuous-flow electroporation platform enabling T cell transfection for cellular therapy manufacturing.
VanderBurgh JA; Corso TN; Levy SL; Craighead HG
Sci Rep; 2023 Apr; 13(1):6857. PubMed ID: 37185305
[TBL] [Abstract][Full Text] [Related]
3. Acoustophoretic rapid media exchange and continuous-flow electrotransfection of primary human T cells for applications in automated cellular therapy manufacturing.
Hsi P; Christianson RJ; Dubay RA; Lissandrello CA; Fiering J; Balestrini JL; Tandon V
Lab Chip; 2019 Sep; 19(18):2978-2992. PubMed ID: 31410419
[TBL] [Abstract][Full Text] [Related]
4. Numerical optimization of microfluidic vortex shedding for genome editing T cells with Cas9.
Jarrell JA; Sytsma BJ; Wilson LH; Pan FL; Lau KHWJ; Kirby GTS; Lievano AA; Pawell RS
Sci Rep; 2021 Jun; 11(1):11818. PubMed ID: 34083685
[TBL] [Abstract][Full Text] [Related]
5. Development of a microfluidic cell transfection device into gene-edited CAR T cell manufacturing workflow.
Yu T; Jhita N; Shankles P; Fedanov A; Kramer N; Raikar SS; Sulchek T
Lab Chip; 2023 Nov; 23(22):4804-4820. PubMed ID: 37830228
[TBL] [Abstract][Full Text] [Related]
6. Microfluidic and Nanofluidic Intracellular Delivery.
Hur J; Chung AJ
Adv Sci (Weinh); 2021 Aug; 8(15):e2004595. PubMed ID: 34096197
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells.
Kamali E; Rahbarizadeh F; Hojati Z; Frödin M
BMC Biotechnol; 2021 Jan; 21(1):9. PubMed ID: 33514392
[TBL] [Abstract][Full Text] [Related]
8. A novel non-viral delivery method that enables efficient engineering of primary human T cells for ex vivo cell therapy applications.
Kavanagh H; Dunne S; Martin DS; McFadden E; Gallagher L; Schwaber J; Leonard S; O'Dea S
Cytotherapy; 2021 Sep; 23(9):852-860. PubMed ID: 33941482
[TBL] [Abstract][Full Text] [Related]
9. Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary Hepatocytes.
Rathbone T; Ates I; Fernando L; Addlestone E; Lee CM; Richards VP; Cottle RN
CRISPR J; 2022 Jun; 5(3):397-409. PubMed ID: 35238624
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer and protein dynamics in stem cells using single cell electroporation in a microfluidic device.
Valero A; Post JN; van Nieuwkasteele JW; Ter Braak PM; Kruijer W; van den Berg A
Lab Chip; 2008 Jan; 8(1):62-7. PubMed ID: 18094762
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
12. Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid.
Tang Q; Liu J; Jiang Y; Zhang M; Mao L; Wang M
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46585-46590. PubMed ID: 31763806
[TBL] [Abstract][Full Text] [Related]
13. Electroporation-Mediated CRISPR/Cas9 Genome Editing in Rat Zygotes.
Davis DJ; Men H; Bryda EC
Methods Mol Biol; 2023; 2631():267-276. PubMed ID: 36995672
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation.
Ma L; Jang L; Chen J; Song J; Yang D; Zhang J; Chen YE; Xu J
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31282887
[TBL] [Abstract][Full Text] [Related]
15. CRISPR Base Editing in Induced Pluripotent Stem Cells.
Chang YJ; Xu CL; Cui X; Bassuk AG; Mahajan VB; Tsai YT; Tsang SH
Methods Mol Biol; 2019; 2045():337-346. PubMed ID: 31250381
[TBL] [Abstract][Full Text] [Related]
16. Genome Editing in Staphylococcus aureus by Conditional Recombineering and CRISPR/Cas9-Mediated Counterselection.
Penewit K; Salipante SJ
Methods Mol Biol; 2020; 2050():127-143. PubMed ID: 31468487
[TBL] [Abstract][Full Text] [Related]
17. An Electrochemical Protocol for CRISPR-Mediated Gene-Editing of Sheep Embryonic Fibroblast Cells.
Eghbalsaied S; Kues WA
Cells Tissues Organs; 2023; 212(2):176-184. PubMed ID: 34823242
[TBL] [Abstract][Full Text] [Related]
18. Delivery of CRISPR-Cas9 into Mouse Zygotes by Electroporation.
Qin W; Wang H
Methods Mol Biol; 2019; 1874():179-190. PubMed ID: 30353514
[TBL] [Abstract][Full Text] [Related]
19. Microfluidic transfection of mRNA into human primary lymphocytes and hematopoietic stem and progenitor cells using ultra-fast physical deformations.
Loo J; Sicher I; Goff A; Kim O; Clary N; Alexeev A; Sulchek T; Zamarayeva A; Han S; Calero-Garcia M
Sci Rep; 2021 Nov; 11(1):21407. PubMed ID: 34725429
[TBL] [Abstract][Full Text] [Related]
20. Efficient CRISPR/Cas9-mediated gene editing in Guangdong small-ear spotted pig cells using an optimized electrotransfection method.
Wei YY; Zhan QM; Zhu XX; Yan AF; Feng J; Liu L; Li JH; Tang DS
Biotechnol Lett; 2020 Nov; 42(11):2091-2109. PubMed ID: 32494996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
